Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anus cancer]

N Keldsen1, S Laurberg

  • 1Onkologisk afdeling D, Arhus Kommmunehospital.

Ugeskrift for Laeger
|July 8, 1996
PubMed
Summary
This summary is machine-generated.

Anal cancer (CA) is a rare but increasing disease, primarily affecting individuals around 60 years old. Current treatments favor sphincter-preserving radiotherapy, with or without chemotherapy, over traditional surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sacral neuromodulation with ultra-low stimulation intensity is effective in faecal incontinence - results from a randomised study with a one-stage implant procedure.

Techniques in coloproctology·2025
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

Long-term efficacy and safety of sacral neuromodulation for diarrhoea-predominant and mixed irritable bowel syndrome.

Techniques in coloproctology·2025
Same author

Stoma reversal after intended restorative rectal cancer resection in Denmark: nationwide population-based study.

BJS open·2020
Same author

Comparison of long-term outcome of sacral nerve stimulation for constipation and faecal incontinence with focus on explantation rate, additional visits, and patient satisfaction.

Techniques in coloproctology·2020
Same author

Cortical processing to anorectal stimuli after rectal resection with and without radiotherapy.

Techniques in coloproctology·2020
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Area of Science:

  • Oncology
  • Epidemiology
  • Pathology

Context:

  • Anal cancer (CA) is a rare malignancy with a rising incidence globally.
  • The median age of diagnosis is 60 years, with higher rates in women.
  • Risk factors include smoking, human papillomavirus (HPV), and human immunodeficiency virus (HIV) infection.

Purpose:

  • To review the pathology, etiology, epidemiology, treatment, and prognostic factors of anal cancer.
  • To highlight current trends in anal cancer incidence and risk factors.
  • To discuss evolving treatment strategies and prognostic indicators.

Summary:

  • The incidence of anal cancer is increasing, particularly in Denmark, affecting approximately 0.7 per 100,000 women and 0.4 per 100,000 men.
  • Key prognostic factors include tumor size, invasion depth, lymph node status, differentiation, and DNA ploidy.

Related Experiment Videos

  • Current treatment paradigms have shifted from abdominoperineal resection to sphincter-preserving approaches using radiotherapy, often combined with chemotherapy, though optimal regimens are still debated.

    • Impact:

    • This review provides a comprehensive overview of anal cancer, aiding clinicians in diagnosis and treatment planning.
    • Understanding prognostic factors and evolving therapies can improve patient outcomes and guide future research.
    • Highlights the need for careful follow-up to manage recurrent disease effectively.